Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study
Open Access
- 11 May 2022
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 12 (5) , e869
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) VariantNew England Journal of Medicine, 2022
- Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous InfectionNew England Journal of Medicine, 2022
- Protection against the Omicron Variant from Previous SARS-CoV-2 InfectionNew England Journal of Medicine, 2022
- Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta VariantClinical Infectious Diseases, 2022
- On the association between COVID-19 vaccination levels and incidence and lethality rates at a regional scale in SpainStochastic Environmental Research and Risk Assessment, 2022
- A Cost–Benefit Analysis of COVID-19 Vaccination in CataloniaVaccines, 2021
- Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19Cell Reports, 2021
- Impact of scaling up SARS-CoV-2 vaccination on COVID-19 hospitalizations in SpainInternational Journal of Infectious Diseases, 2021
- Immunological mechanisms of vaccine-induced protection against COVID-19 in humansNature Reviews Immunology, 2021
- IgA dominates the early neutralizing antibody response to SARS-CoV-2Science Translational Medicine, 2021